No definition available.
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleNone |
520210 |
2. Check conditionsNone |
520210 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
2 out of 7 registries used, show all original rules. |
388 |
4. Check minimum number of eventsNone |
388 |
5. Include endpointsNone |
388 |
6. Filter based on genotype QC (FinnGen only) |
388 |
Control definitions (FinnGen only)
- Control exclude
- G6_NEUINFL
Extra metadata
- Level in the ICD hierarchy
- 3
- First used in FinnGen datafreeze
- DF2
Similar endpoints
↥List of similar endpoints to
Intracranial and intraspinal abscess and granuloma
based on the number of shared cases.
Similar with more cases:
- Inflammatory diseases of the central nervous system
- Neurological diseases
- Neurological diseases, wide definition
- Any event in hilmo or specialist outpatient
Similar with less cases:
None
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | |||
| Whole population | 3266 | 1188 | 2050 |
| Only index persons | 2599 | 978 | 1621 |
| Unadjusted period prevalence (%) | |||
| Whole population | 0.05 | 0.03 | 0.06 |
| Only index persons | 0.05 | 0.04 | 0.06 |
| Median age at first event (years) | |||
| Whole population | 56.24 | 57.43 | 55.51 |
| Only index persons | 55.94 | 56.94 | 55.33 |
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 388 | 155 | 233 |
| Unadjusted period prevalence (%) | 0.08 | 0.05 | 0.10 |
| Median age at first event (years) | 59.25 | 56.49 | 61.09 |
-FinRegistry-
Age distribution of first events
-FinnGen-
Age distribution of first events
-FinRegistry-
Year distribution of first events
-FinnGen-
Year distribution of first events
-FinRegistry-
Cumulative Incidence Function
-FinnGen-
Cumulative Incidence Function
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 352
- Matched controls
- 3520
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
G06.1
ICD-10 Finland
Intraspinal abscess and granuloma
+∞
191.7
166
*
G06.0
ICD-10 Finland
Intracranial abscess and granuloma
+∞
143.9
128
*
A41.0
ICD-10 Finland
Sepsis due to Staphylococcus aureus
42.2
75.5
94
30
G06.2
ICD-10 Finland
Extradural and subdural abscess, unspecified
+∞
48.0
45
*
J04AB02
ATC
rifampicin; systemic
43.5
40.0
49
13
M46.3
ICD-10 Finland
Infection of intervertebral disc (pyogenic)
118.8
39.7
42
*
A49.9
ICD-10 Finland
Bacterial infection, unspecified
7.0
36.7
101
192
TPH15
NOMESCO Finland
Insertion of central venous catheter through external or internal jugular vein
9.2
36.0
80
109
M46.4
ICD-10 Finland
Discitis, unspecified
62.4
34.0
39
7
NA3CG
NOMESCO Finland
Lumbar spine extensive MRI examination with high intensity magnet
12.9
31.4
57
52
GD1UA
NOMESCO Finland
Thorax X-ray examination outside radiological department
4.9
30.7
118
328
AAM00
NOMESCO Finland
Puncture and evacuation of intracerebral abscess
+∞
28.5
27
*
GD1QA
NOMESCO Finland
Supine thorax X-ray examination
4.6
28.5
116
339
NA3DG
NOMESCO Finland
Lumbar spine very extensive MRI examination with high intensity magnet
51.8
28.0
33
7
WX700
NOMESCO Finland
Respiratory and circulatory monitoring
4.6
27.8
113
328
AA1CD
NOMESCO Finland
Very extensive CT of head and brain
24.9
25.8
36
16
AA1AD
NOMESCO Finland
CT of head and brain
3.7
24.9
137
516
WX408
NOMESCO Finland
General anesthesy, balanced
3.5
24.5
148
599
AA1CG
NOMESCO Finland
Extensive MRI examination of brain with high intensity magnet
6.1
24.1
70
137
JN4BD
NOMESCO Finland
Extensive body CT
4.8
23.2
86
223
J01FF01
ATC
clindamycin; systemic
3.4
23.1
150
636
TPH20
NOMESCO Finland
Insertion of central venous catheter through subclavian or brachiocephalic vein
11.5
21.8
41
40
N03AX14
ATC
levetiracetam; systemic
12.8
21.3
38
33
AAM30
NOMESCO Finland
Evacuation of epidural or subdural empyema
+∞
21.0
20
*
111
Kela drug reimbursment
Epilepsy and comparable convulsive disorders
7.7
21.0
50
74
B18.2
ICD-10 Finland
Chronic viral hepatitis C
44.7
20.7
25
6
NA1CG
NOMESCO Finland
Cervical spine extensive MRI examination with high intensity magnet
17.1
19.2
30
19
FM1BE
NOMESCO Finland
Cardiac ultrasound examination through oesophagus
5.3
19.1
62
137
AA1BD
NOMESCO Finland
Extensive CT of head and brain
11.0
18.9
36
36
GD1AA
NOMESCO Finland
Thorax X-ray examination
2.8
18.9
196
1093
NA7DG
NOMESCO Finland
Spine and spinal cord very extensive MRI examination with high intensity magnet
15.5
18.5
30
21
N02AA05
ATC
oxycodone; systemic
3.7
17.7
88
293
NA7CG
NOMESCO Finland
Spine and spinal cord extensive MRI examination with high intensity magnet
18.2
17.7
27
16
TPH04
NOMESCO Finland
Cathetrisation of vein
3.2
17.3
109
434
R4110
NOMESCO Finland
Physiotherapy
3.0
17.1
128
570
AA1DG
NOMESCO Finland
Very extensive MRI examination of brain with high intensity magnet
9.8
16.9
34
38
182
Kela drug reimbursment
Brivaracetam, eslikarbazepin, gabapentin, lacosamide, levetiracetam, perampanel, pregabalin, tiagabin and zonisamide
13.7
16.5
28
22
J01CF05
ATC
flucloxacillin; systemic
8.1
16.4
37
50
TPH30
NOMESCO Finland
Insertion of central venous catheter through periferal vein
12.6
15.9
28
24
AAM10
NOMESCO Finland
Excision of intracerebral abscess
+∞
15.7
15
*
R50.9
ICD-10 Finland
Fever, unspecified
3.4
15.1
81
283
G40.29
ICD-10 Finland
Localization-related (focal)(partial) symptomatic epilepsy and epileptic syndromes with complex partial seizures
11.1
14.5
27
26
A41.9
ICD-10 Finland
Sepsis, unspecified
6.8
14.2
36
58
TKC20
NOMESCO Finland
Catheterisation of bladder
4.7
14.1
49
116
WYA30
NOMESCO Finland
Preparations for expected poor cooperation
5.3
14.1
44
93
NA2BG
NOMESCO Finland
Thoracal spine MRI examination with high intensity magnet
11.6
13.7
25
23
NAS20
NOMESCO Finland
Incision and debridement of infection of vertebra, unspecified
+∞
13.6
13
*
J01MA12
ATC
levofloxacin; systemic
2.9
13.6
95
396
N03AX16
ATC
pregabalin; oral
2.7
13.1
110
513
G40.9
ICD-10 Finland
Epilepsy, unspecified
7.5
12.9
30
43
FM1AE
NOMESCO Finland
Standard cardiac ultrasound examination
2.9
12.8
86
349
N02AX02
ATC
tramadol; systemic, rectal
2.3
12.6
173
1039
L28
ICPC
Limited function/disability (L)
3.0
12.1
75
288
NA1DG
NOMESCO Finland
Cervical spine very extensive MRI examination with high intensity magnet
31.2
11.7
15
5
G09
ICD-10 Finland
Sequelae of inflammatory diseases of central nervous system
+∞
11.5
11
*
T36
ICD-10 Finland
Poisoning by systemic antibiotics
6.5
11.3
29
48
G40.22
ICD-10 Finland
Complex partial epileptic seizure with secondary generalization
13.3
11.3
19
15
WX892
NOMESCO Finland
Monitored bed care
4.1
11.2
44
118
PH2AE
NOMESCO Finland
Ultrasound examination of lower leg veins
3.4
10.8
55
183
ZXM00
NOMESCO Finland
Intraoperative use of ultrasonographic imaging
18.6
10.8
16
9
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
3.0
10.7
67
257
EB1HA
NOMESCO Finland
Panorama tomography of teeth and jaws or similar X-ray examination
2.2
10.6
150
893
WX110
NOMESCO Finland
Local anesthesy
2.2
10.6
248
1835
AAK00
NOMESCO Finland
Cranioplasty
113.3
10.5
11
*
AWC00
NOMESCO Finland
Reoperation of nervous system because of deep wound infection in the nervous system
113.3
10.5
11
*
G00.9
ICD-10 Finland
Bacterial meningitis, unspecified
+∞
10.5
10
*
32200
ICD-8 Finland
Intracranial and intraspinal abscess, Intracerebralis
+∞
10.5
10
*
N03AX18
ATC
lacosamide; systemic
19.5
10.3
15
8
ZXC95
NOMESCO Finland
Use of surgical navigator
13.7
10.3
17
13
Y83
ICD-10 Finland
Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
3.8
10.1
44
129
J18.9
ICD-10 Finland
Pneumonia, unspecified
2.4
10.1
96
470
T81.4
ICD-10 Finland
Infection following a procedure, not elsewhere classified
3.2
10.1
56
197
NA3AA
NOMESCO Finland
Lumbar spine X-ray examination without contrast
3.3
10.1
52
175
A46
ICD-10 Finland
Erysipelas
2.9
10.0
67
267
NA2CG
NOMESCO Finland
Thoracal spine extensive MRI examination with high intensity magnet
15.6
9.6
15
10
I33.0
ICD-10 Finland
Acute and subacute infective endocarditis
15.6
9.6
15
10
AA1BG
NOMESCO Finland
Standard MRI examination of brain with high intensity magnet
3.5
9.5
45
142
M46.2
ICD-10 Finland
Osteomyelitis of vertebra
+∞
9.4
9
*
3240A
ICD-9 Finland
Intracranial and intraspinal abscess, Intracranial abscess
+∞
9.4
9
*
ABC36
NOMESCO Finland
Decompression of lumbar nerve roots
4.0
9.4
37
100
N10
ICD-10 Finland
Acute tubulo-interstitial nephritis
2.9
9.2
59
227
F11.22
ICD-10 Finland
Addiction-induced dependence is currently independent but uses substitute intermittent medication
37.7
9.1
11
*
I63.9
ICD-10 Finland
Cerebral infarction, unspecified
3.1
9.0
50
176
X69
ICD-10 Finland
Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances
7.1
9.0
21
31
X59
ICD-10 Finland
Exposure to unspecified factor
2.4
8.9
80
379
XF400
NOMESCO Finland
ECG with 12 standard connections
2.6
8.8
72
322
WX404
NOMESCO Finland
Intravenous generell anesthesy
2.4
8.8
86
425
R4120
NOMESCO Finland
Occupational therapy
3.8
8.7
36
102
A40.8
ICD-10 Finland
Other streptococcal sepsis
10.4
8.6
16
16
N03AB02
ATC
phenytoin; systemic
16.8
8.6
13
8
AA1DM
NOMESCO Finland
Very extensive MRI examination of brain with 3 Tesla magnet
16.8
8.6
13
8
GD1PA
NOMESCO Finland
X-ray examination of the lungs in one projection
3.1
8.6
49
177
EBA15
NOMESCO Finland
Extraction of large number of teeth
4.6
8.5
29
68
QX2XE
NOMESCO Finland
Ultrsound examination of soft tissue not elsewhere classified
7.0
8.5
20
30
NA3BG
NOMESCO Finland
Lumbar spine MRI examination with high intensity magnet
3.1
8.5
47
165
F11.29
ICD-10 Finland
Addiction caused by opiates UNS
+∞
8.4
8
*
AAG00
NOMESCO Finland
Stereotactic intracranial biopsy
+∞
8.4
8
*
KH1AE
NOMESCO Finland
Urinary tract ultrasound examination
3.7
8.3
36
106
ABC60
NOMESCO Finland
Decompression of cervical spinal cord
14.9
8.3
13
9
A41.5
ICD-10 Finland
Sepsis due to other Gram-negative organisms
5.5
8.2
23
44
XA800
NOMESCO Finland
Neuropsychological investigation
4.7
7.9
26
59
IAZ97
NOMESCO Finland
Psychiatric consultation in another specialty
13.4
7.9
13
10
ZXA00
NOMESCO Finland
Right side
2.1
7.9
107
609
WX882
NOMESCO Finland
High dependency care
6.2
7.8
20
34
N02BE01
ATC
paracetamol; systemic, rectal
2.3
7.8
300
2529
P19
ICPC
Drug abuse
15.5
7.8
12
8
AWB00
NOMESCO Finland
Reoperation for superficial infection in surgery of the nervous system
46.0
7.7
9
*
G95.8
ICD-10 Finland
Other specified diseases of spinal cord
46.0
7.7
9
*
F15.1
ICD-10 Finland
Mental and behavioural disorders due to use of other stimulants, including caffeine, harmful use
46.0
7.7
9
*
A41.8
ICD-10 Finland
Other specified sepsis
7.0
7.7
18
27
EBA10
NOMESCO Finland
Surgical removal of tooth
2.9
7.7
48
184
A28
ICPC
Limited function/disability NOS
2.5
7.7
65
296
AAA10
NOMESCO Finland
Biopsy through craniotomy
25.6
7.6
10
*
M00.0
ICD-10 Finland
Staphylococcal arthritis and polyarthritis
25.6
7.6
10
*
N05BA01
ATC
diazepam; systemic, rectal
2.5
7.5
60
267
WZC10
NOMESCO Finland
Extensive specialist consultion with written report
4.4
7.5
26
63
AAD10
NOMESCO Finland
Evacuation of chronic subdural haematoma
9.7
7.3
14
15
N02AE01
ATC
buprenorphine; parenteral, sublingual, transdermal
2.7
7.3
52
214
L97
ICD-10 Finland
Ulcer of lower limb, not elsewhere classified
4.6
7.3
24
55
WX872
NOMESCO Finland
Intensive care
3.5
7.2
32
97
F19.1
ICD-10 Finland
Mental and behavioural disorders due to multiple drug use and use of other psychoactive substances, harmful use
30.7
7.2
9
*
F11.25
ICD-10 Finland
Relationship caused by opiates continuously used
30.7
7.2
9
*
Z72.2
ICD-10 Finland
Drug use
20.5
7.2
10
5
S06.5
ICD-10 Finland
Traumatic subdural haemorrhage
4.9
7.2
22
47
SPAT1255
SPAT
Intravenous administration of medicine
3.1
7.1
38
132
B01AB05
ATC
enoxaparin; parenteral
2.0
7.1
111
663
F10.29
ICD-10 Finland
Addiction caused by alcohol UNS
6.6
7.0
17
27
A04.7
ICD-10 Finland
Enterocolitis due to Clostridium difficile
6.1
7.0
18
31
N03AF01
ATC
carbamazepine; oral, rectal
4.3
6.8
24
59
M54.5
ICD-10 Finland
Low back pain
1.9
6.8
117
724
T91.3
ICD-10 Finland
Sequelae of injury of spinal cord
40.9
6.8
8
*
J01XX08
ATC
linezolid; systemic
17.1
6.8
10
6
M79.6
ICD-10 Finland
Pain in limb
1.9
6.8
115
708
NA1AA
NOMESCO Finland
Cervical spine X-ray examination without contrast
4.8
6.7
21
46
NK5AT
NOMESCO Finland
Joint injection with ultrasound guidance not elsewhere classified
23.0
6.7
9
*
N03AX12
ATC
gabapentin; oral
2.3
6.7
62
296
WX002
NOMESCO Finland
Sedation and analgesia
2.1
6.7
78
413
R60.0
ICD-10 Finland
Localized oedema
2.8
6.7
42
162
TPH07
NOMESCO Finland
Cathetrisation of artery
2.6
6.6
49
208
R56.8
ICD-10 Finland
Other and unspecified convulsions
3.9
6.6
26
71
F10.24
ICD-10 Finland
Alcohol depence active use
9.0
6.6
13
15
ZXM10
NOMESCO Finland
Intraoperative use of conventional X-ray imaging
3.4
6.6
30
93
C03CA01
ATC
furosemide; systemic
1.9
6.5
110
674
G40.10
ICD-10 Finland
Simple partial seizures
14.7
6.4
10
7
M54.9
ICD-10 Finland
Dorsalgia, unspecified
2.7
6.4
44
178
F10.25
ICD-10 Finland
Alcohol dependence continuous use
6.8
6.4
15
23
Z46.3
ICD-10 Finland
Fitting and adjustment of dental prosthetic device
8.4
6.4
13
16
K90
ICPC
Stroke/cerebrovascular accident
6.2
6.4
16
27
A06AD11
ATC
lactulose; oral
2.4
6.3
55
254
F19.29
ICD-10 Finland
Addiction caused by several drugs in combination and by other psychoactive substances UNS
18.4
6.3
9
5
J01DB01
ATC
cefalexin; oral
1.9
6.3
282
2375
F11.24
ICD-10 Finland
Addiction-induced dependence caused by opiates active addiction
+∞
6.3
6
*
D43.2
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Brain, unspecified
+∞
6.3
6
*
N02AA59
ATC
codeine, combinations excl. psycholeptics; systemic
1.8
6.2
163
1152
TPX10
NOMESCO Finland
Implantation of vascular injection port
4.8
6.2
19
41
L02.4
ICD-10 Finland
Cutaneous abscess, furuncle and carbuncle of limb
4.8
6.2
19
41
H02AB07
ATC
prednisone; oral
2.3
6.2
58
277
P15
ICPC
Chronic alcohol abuse
5.4
6.1
17
33
Z50.8
ICD-10 Finland
Care involving use of other rehabilitation procedures
3.0
6.1
34
120
N18
ICPC
Paralysis/weakness
6.2
6.1
15
25
R33
ICD-10 Finland
Retention of urine
2.8
6.0
38
146
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
90
63
18.30
103.21
1.8
1.6
—
—
—
0
0
(3042936) Bacteria identified in Isolate by Culture
171
473
5.68
61.55
3.4
2.1
—
—
—
0
0
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
70
78
10.73
59.08
1.5
1.5
—
—
—
0
0
(3023368) Bacteria identified in Blood by Culture
235
881
5.23
57.74
11.1
4.4
—
—
—
0
0
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
71
110
7.68
45.53
2.2
2.8
—
—
—
0
0
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
91
236
4.73
33.32
2.1
1.5
—
—
—
0
0
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
50
86
6.53
28.67
3.6
2.2
u/ml
0.3
0.3
0.72
30
47
(3016914) Bacteria identified in Cerebral spinal fluid by Culture
29
25
12.46
28.58
3.3
1.2
—
—
—
0
0
(42870588) Differential panel, method unspecified - Blood
210
1039
3.23
28.53
14.2
5.9
—
—
—
0
0
(3003458) Phosphate [Moles/volume] in Serum or Plasma
118
412
3.68
28.35
7.4
5.8
mmol/l
1.1
1.0
0.43
109
384
(46235355) HIV 1 and 2 tests - Meaningful Use set
123
471
3.36
25.24
1.9
1.8
—
—
—
0
0
(3020779) Urea [Moles/volume] in Serum or Plasma
87
271
3.85
24.44
10.2
7.4
mmol/l
9.3
10.1
0.54
81
254
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
42
72
6.42
24.07
1.5
1.4
—
—
—
0
0
(3022096) Basophils/100 leukocytes in Blood
244
1426
2.92
22.83
16.1
6.4
%
0.6
0.7
1.09
235
1334
(3012095) Magnesium [Moles/volume] in Serum or Plasma
126
522
3.09
22.30
5.6
3.3
mmol/l
0.8
0.8
2.17
120
489
(3006504) Eosinophils/100 leukocytes in Blood
246
1470
2.84
21.60
16.4
6.3
%
2.9
2.8
0.11
237
1376
(3001604) Monocytes [#/volume] in Blood
255
1563
2.84
21.13
15.3
6.2
e9/l
0.7
0.6
3.47
225
1371
(3019069) Monocytes/100 leukocytes in Blood
245
1477
2.79
20.87
16.8
6.6
%
9.2
8.8
0.89
237
1392
(3024561) Albumin [Mass/volume] in Serum or Plasma
228
1326
2.74
20.85
9.0
5.0
g/l
31.9
35.5
10.67
219
1239
(3006315) Basophils [#/volume] in Blood
255
1570
2.82
20.82
15.6
6.2
e9/l
0.0
0.0
0.18
225
1384
(3002030) Lymphocytes/100 leukocytes in Blood
248
1511
2.78
20.57
16.2
6.5
%
24.4
27.4
4.79
238
1415
(3018010) Neutrophils/100 leukocytes in Blood
245
1486
2.76
20.47
15.9
6.3
%
60.0
57.4
3.07
235
1402
(3019198) Lymphocytes [#/volume] in Blood
257
1599
2.80
20.38
15.4
6.4
e9/l
1.8
1.9
0.81
232
1441
(3044640) Blood type and Crossmatch panel - Blood
183
969
2.68
19.97
4.4
2.3
—
—
—
0
0
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
260
1638
2.78
19.92
11.8
6.9
umol/l
10.9
11.7
0.49
251
1564
(3005719) IgG [Mass/volume] in Serum or Plasma
75
243
3.59
19.63
3.6
2.4
g/l
11.6
10.6
0.70
70
220
(3013115) Eosinophils [#/volume] in Blood
257
1622
2.73
19.41
16.1
6.5
e9/l
0.2
0.2
0.38
229
1452
(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood
23
25
9.72
19.27
1.7
1.5
—
—
—
0
0
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
119
517
2.88
18.94
2.3
1.9
—
—
—
0
0
(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy
17
12
14.77
18.59
3.8
1.2
—
—
—
0
0
(3044290) Cell count panel - Cerebral spinal fluid
31
52
6.39
18.06
3.4
1.4
—
—
—
0
0
(3027946) Carbon dioxide [Partial pressure] in Arterial blood
97
387
3.01
17.93
12.1
8.7
kpa
5.0
5.1
0.48
91
368
(3027801) Oxygen [Partial pressure] in Arterial blood
97
387
3.01
17.93
12.1
8.7
kpa
13.2
12.2
1.07
91
370
(3013742) Prealbumin [Mass/volume] in Serum or Plasma
82
297
3.23
17.89
2.9
2.5
g/l
0.2
0.2
1.48
77
276
(3007853) Bacteria identified in Skin by Aerobe culture
94
369
3.04
17.87
2.7
1.6
—
—
—
0
0
(3013650) Neutrophils [#/volume] in Blood by Automated count
273
1816
2.70
17.85
18.4
9.8
e9/l
4.4
4.1
1.32
240
1604
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
148
739
2.62
17.76
4.2
2.3
—
—
—
0
0
(3016018) Differential panel - Cerebral spinal fluid
19
18
11.05
17.45
3.6
1.1
—
—
—
0
0
(3026008) Bacteria identified in Urine by Culture
163
859
2.55
17.41
4.8
3.1
—
—
—
0
0
(3003396) Base excess in Arterial blood by calculation
96
389
2.95
17.19
12.1
8.8
mmol/l
0.8
1.1
0.29
76
315
(3016543) Leukocytes [#/volume] in Cerebral spinal fluid
32
59
5.82
16.95
3.0
1.3
e6/l
270.4
15.4
0.65
24
47
(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid
32
59
5.82
16.95
3.1
1.4
e6/l
318.4
1933.1
0.43
25
49
(3012336) Haptoglobin [Mass/volume] in Serum or Plasma
53
149
3.96
16.95
1.8
2.1
g/l
2.0
1.5
2.68
47
128
(3002582) Erythrocytes [#/volume] in Urine
173
951
2.48
16.72
4.2
3.1
e6/l
41.1
109.4
0.50
137
751
(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count
194
1126
2.45
16.60
4.5
3.1
—
—
—
0
0
(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection
19
20
9.94
16.23
2.5
1.5
—
—
—
0
0
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
222
1395
2.38
15.54
11.6
6.3
mmol/l
1.2
1.2
2.14
207
1267
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
144
755
2.44
15.14
3.0
2.0
mg/l
3.3
3.2
0.22
125
653
(36304419) Bacteria [Presence] in Urine
153
835
2.37
14.60
4.5
3.0
—
—
—
0
0
(3018095) Leukocytes [#/volume] in Urine
183
1087
2.29
14.24
5.0
3.6
e6/l
105.3
90.3
0.14
141
804
(3026782) Osmolality of Urine
124
623
2.46
14.17
3.3
2.8
mosm/kgh2o
525.8
572.8
1.61
109
528
(3030467) Casts [#/volume] in Urine by Automated count
156
869
2.33
14.10
4.4
3.0
e6/l
0.4
0.5
0.62
123
666
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
233
1535
2.30
14.06
13.0
7.2
mmol/l
1.2
1.2
1.48
206
1306
(3013826) Glucose [Moles/volume] in Serum or Plasma
267
1874
2.36
13.71
10.0
5.1
mmol/l
6.7
6.8
0.28
254
1766
(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma
72
280
2.93
13.68
3.5
2.5
u/l
218.9
33.0
0.50
62
240
(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
14
12
12.07
13.60
1.3
1.1
—
—
—
0
0
(3032080) INR in Blood by Coagulation assay
205
1307
2.21
13.08
11.0
8.9
inr
1.2
1.3
0.55
43
362
(3021589) Normoblasts [#/volume] in Blood
210
1360
2.19
12.78
18.9
9.7
e9/l
0.0
0.0
0.54
169
1138
(3000494) Fungus identified in Specimen by Culture
88
394
2.60
12.70
1.9
1.4
—
—
—
0
0
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
74
314
2.68
11.84
5.1
3.3
—
—
—
0
0
(3000764) Benzodiazepines [Presence] in Urine
36
99
3.91
11.80
10.6
1.7
—
—
—
0
0
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
101
499
2.38
11.71
3.7
2.8
e6/l
2.1
2.0
0.08
61
286
(3014576) Chloride [Moles/volume] in Serum or Plasma
91
430
2.46
11.64
11.7
6.5
mmol/l
105.0
104.0
1.01
91
417
(3028300) Cannabinoids [Presence] in Urine
36
100
3.87
11.63
10.8
1.7
—
—
—
0
0
(3027008) Opiates [Presence] in Urine
36
100
3.87
11.63
10.4
1.7
—
—
—
0
0
(1001926) Buprenorphine [Presence] in Urine by Screen method
31
77
4.29
11.63
11.4
1.6
—
—
—
0
0
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
213
1426
2.09
11.44
5.9
4.1
—
—
—
0
0
(3021788) Differential panel - Synovial fluid
23
45
5.37
11.40
1.9
1.6
—
—
—
0
0
(4062490)
19
31
6.39
11.30
1.6
1.2
—
—
—
0
0
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
91
436
2.42
11.26
3.1
2.3
%
21.1
23.0
0.45
84
377
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
82
375
2.50
11.22
5.3
3.1
umol/l
8.9
9.4
0.07
68
332
(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
28
66
4.49
11.21
4.5
8.0
iu/ml
454.7
263.0
—
6
14
(3028707) Methadone [Presence] in Urine by Screen method
23
46
5.25
11.13
14.4
2.0
—
—
—
0
0
(3017143) Hepatitis C virus Ab [Presence] in Serum
77
343
2.55
11.13
1.8
1.6
—
—
—
0
0
(3016879) Cocaine [Presence] in Urine
34
94
3.87
11.06
11.0
1.8
—
—
—
0
0
(3000991) Gas panel - Venous blood
66
277
2.67
10.74
16.4
8.2
—
—
—
0
0
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
80
369
2.47
10.72
2.2
1.8
—
—
—
0
0
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
84
397
2.42
10.67
1.9
1.6
—
—
—
0
0
(3000850) Epithelial cells [#/volume] in Urine
120
660
2.18
10.67
3.1
2.5
e6/l
8.4
5.4
0.60
105
577
(3023520) Reticulocytes [#/volume] in Blood
65
273
2.66
10.56
2.4
2.8
e9/l
61.2
72.0
1.23
45
214
(3011288) Drugs identified in Urine by Screen method
27
65
4.39
10.53
7.2
2.3
—
—
—
0
0
(3004789) Transferrin [Mass/volume] in Serum or Plasma
93
463
2.33
10.49
3.2
2.2
g/l
2.2
2.3
1.71
88
427
(3023410) Appearance of Cerebral spinal fluid
17
27
6.54
10.35
3.8
1.5
—
—
—
0
0
(40758558) Short blood count panel - Blood
135
785
2.10
10.35
14.7
7.4
—
—
—
0
0
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
13
15
8.93
10.29
1.3
1.1
—
—
—
0
0
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
109
591
2.17
9.95
4.1
3.9
ng/l
715.3
226.3
0.73
88
475
(3027945) Reticulocytes/100 erythrocytes in Blood
79
375
2.39
9.89
2.7
2.7
%
1.5
1.8
2.41
72
333
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
101
535
2.20
9.76
3.7
2.6
e6/l
1.4
1.0
0.58
61
316
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
78
371
2.38
9.71
2.2
1.8
—
—
—
0
0
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
32
93
3.66
9.69
1.4
1.2
—
—
—
0
0
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
304
2403
2.22
9.66
20.0
8.0
u/l
90.8
77.7
4.58
296
2255
(3027944) Amphetamines [Presence] in Urine
33
100
3.51
9.40
10.9
1.7
—
—
—
0
0
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
32
95
3.58
9.40
1.7
1.1
—
—
—
0
0
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
186
1249
1.94
9.26
2.3
2.0
pmol/l
99.8
94.9
0.59
97
662
(3028308) Erythrocytes [#/volume] in Pleural fluid
15
24
6.46
9.06
1.5
1.5
e6/l
23864.2
37139.3
—
10
15
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
47
183
2.78
8.80
2.0
1.6
—
—
—
0
0
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
157
1015
1.92
8.60
4.0
2.6
u/l
57.8
57.1
0.07
145
946
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
24
62
4.06
8.55
1.3
1.5
—
—
—
0
0
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
24
62
4.06
8.55
1.3
1.5
—
—
—
0
0
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
35
117
3.19
8.55
2.3
2.0
—
—
—
0
0
(3002032) Base excess in Venous blood by calculation
65
302
2.38
8.48
8.5
3.7
mmol/l
0.6
2.1
2.06
59
246
(3023199) Leukocytes [#/volume] in Pleural fluid
15
26
5.96
8.39
1.5
1.5
e6/l
2729.4
2226.8
—
10
20
(3021879) Hepatitis B virus core Ab [Presence] in Serum
52
220
2.57
8.27
1.8
1.5
—
—
—
0
0
(3013707) Erythrocyte sedimentation rate by Westergren method
289
2296
2.01
8.25
7.5
4.0
mm/h
22.0
12.0
11.78
275
2100
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
176
1193
1.87
8.24
2.6
2.3
nmol/l
73.2
76.3
0.67
157
1056
(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
161
1063
1.88
8.17
6.3
3.7
u/l
36.9
32.4
1.00
154
1016
(3012544) pH of Venous blood
66
314
2.33
8.15
8.6
3.7
—
—
—
0
0
(3019309) Folate [Moles/volume] in Red Blood Cells
104
599
2.01
7.88
1.8
1.7
nmol/l
1014.8
1186.7
1.24
80
456
(4198724)
11
15
7.52
7.59
1.6
1.9
—
—
—
0
0
(3024928) Oxygen saturation in Venous blood
23
64
3.76
7.41
4.3
2.8
—
—
—
0
0
(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum
44
181
2.61
7.40
1.4
1.2
—
33.4
—
0
11
(3002179) Metamyelocytes/100 leukocytes in Blood
53
240
2.40
7.29
4.8
4.5
%
0.8
0.4
0.62
22
64
(3051611) Lipemic interference index of Serum or Plasma
16
34
4.87
7.23
5.3
2.6
—
—
—
0
0
(3018418) pH of Serum or Plasma
140
914
1.83
7.16
6.7
4.0
ph
7.4
7.4
0.46
24
163
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
25
76
3.45
7.09
1.5
1.3
—
—
—
0
0
(21494890) Protein electrophoresis panel - 24 hour Urine
14
27
5.34
7.02
1.1
3.6
—
—
—
0
0
(3045788) Cell count panel - Pleural fluid
12
20
6.16
6.94
1.8
1.5
—
—
—
0
0
(3001122) Ferritin [Mass/volume] in Serum or Plasma
181
1289
1.76
6.82
3.5
2.6
ug/l
191.0
146.2
0.90
166
1181
(3021236) Streptolysin O Ab [Units/volume] in Serum or Plasma
11
17
6.63
6.81
1.2
1.2
iu/ml
497.4
187.0
0.61
11
17
(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid
14
28
5.15
6.75
1.3
1.0
—
—
—
0
0
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
26
84
3.25
6.72
1.4
1.7
—
—
—
0
0
(3004588) Protein electrophoresis panel - Serum or Plasma
46
203
2.44
6.69
2.8
3.0
—
—
—
0
0
(3027544) Mycobacterium sp identified in Sputum by Organism specific culture
16
37
4.47
6.55
3.0
3.6
—
—
—
0
0
(3009343) pH of Capillary blood
47
212
2.38
6.51
3.9
3.4
ph
7.4
7.4
—
6
24
(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture
15
33
4.69
6.51
2.1
2.1
—
—
—
0
0
(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum
14
29
4.97
6.50
1.1
1.2
—
—
—
0
0
(3037467) Urinalysis macro (dipstick) panel - Urine
265
2120
1.79
6.50
7.4
4.4
—
—
—
0
0
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
19
51
3.87
6.44
1.3
1.2
—
—
—
0
0
(3022217) INR in Platelet poor plasma by Coagulation assay
75
411
2.02
6.43
22.9
22.8
inr
1.2
1.3
0.35
11
52
(3042631) Mycobacterium sp identified in Specimen
17
42
4.19
6.42
1.8
3.1
—
—
—
0
0
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
21
61
3.58
6.38
1.3
1.2
—
—
—
0
0
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
30
110
2.87
6.27
2.2
1.8
—
—
—
0
0
(3044941) Cell count panel - Synovial fluid
16
39
4.24
6.15
2.4
1.5
—
—
—
0
0
(3000475) Leukocytes [#/volume] in Synovial fluid
23
73
3.29
6.12
2.1
1.6
e6/l
15656.9
17074.3
0.06
13
57
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
45
205
2.35
6.10
3.9
3.4
mmol/l
2.3
1.6
0.67
38
152
(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum
14
31
4.65
6.03
2.4
2.3
—
—
—
0
0
(3052851) Hemolysis interference index of Serum or Plasma
27
96
2.95
5.96
5.6
3.4
—
—
—
0
0
(3048929) Epstein Barr virus Ab [Presence] in Serum
25
85
3.07
5.96
1.2
1.2
—
—
—
0
0
(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
28
102
2.88
5.93
4.0
3.0
g/l
3.1
3.2
0.09
22
84
(3024354) Oxygen [Partial pressure] in Venous blood
52
256
2.19
5.88
6.9
2.9
kpa
5.3
4.4
1.49
52
247
(1616796) Gas panel - Central venous blood
21
65
3.36
5.81
3.8
2.7
—
—
—
0
0
(3012441) Differential panel - Pleural fluid
13
28
4.77
5.78
1.5
1.6
—
—
—
0
0
(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma
46
217
2.27
5.76
5.7
3.9
ng/l
99.4
81.3
0.46
41
198
(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
29
110
2.77
5.71
3.9
2.9
g/l
7.7
7.4
0.28
22
87
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
29
110
2.77
5.71
3.9
2.9
—
—
—
0
0
(3010421) pH of Blood
22
71
3.22
5.71
4.2
3.1
ph
7.4
7.4
0.24
16
59
(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid
11
21
5.36
5.55
1.0
1.0
—
—
—
0
0
(3051651) Icteric interference index of Serum or Plasma
12
25
4.92
5.53
5.6
2.5
—
—
—
0
0
(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection
8
5
16.28
5.43
2.3
1.4
—
—
—
0
0
(3017181) Myelocytes/100 leukocytes in Blood
52
267
2.09
5.28
5.3
4.6
%
0.8
0.8
0.09
25
89
(3012501) Base excess in Blood by calculation
19
59
3.33
5.24
4.5
3.1
mmol/l
2.2
2.2
0.02
14
38
(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum
19
59
3.33
5.24
1.3
1.2
u/ml
216.3
309.3
0.72
12
32
(3026480) Teichoate Ab [Titer] in Serum
5
0
+∞
5.22
1.0
0.0
—
—
—
0
0
(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
28
110
2.67
5.17
4.0
2.9
g/l
4.3
3.8
0.49
21
83
(3021440) Promyelocytes/100 leukocytes in Blood
49
248
2.12
5.17
5.4
4.8
%
0.1
0.2
0.64
24
82
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
40
187
2.27
5.12
1.6
1.4
—
—
—
0
0
(3017817) Protein [Mass] in Urine collected for unspecified duration
12
27
4.55
5.07
1.8
3.2
—
—
—
0
0
(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
9
9
10.20
5.05
1.6
1.1
—
—
—
0
0
(3008757) Leukocyte morphology finding [Identifier] in Blood
15
41
3.77
4.97
6.2
3.2
—
—
—
0
0
(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood
24
89
2.81
4.94
1.4
1.6
iu/ml
0.0
0.1
—
7
20
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
38
180
2.23
4.72
19.4
12.3
—
—
—
0
0
(1761868) Lipid panel - Serum or Plasma
76
1163
0.57
4.65
3.1
2.9
—
—
—
0
0
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
102
679
1.68
4.57
2.0
1.7
mg/l
1.9
1.3
0.80
86
523
(3009508) Creatinine [Moles/volume] in Urine
140
1015
1.59
4.45
5.7
3.1
mmol/l
6.7
8.0
2.12
113
843
(3025159) Blasts/100 leukocytes in Blood
45
234
2.04
4.43
5.2
4.8
%
3.6
0.1
0.46
22
68
(40760888) Immunoglobulin light chains.free panel - Serum
21
77
2.83
4.42
2.1
5.2
—
—
—
0
0
(3015635) Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma
18
61
3.05
4.34
1.4
1.4
—
—
—
0
0
(40768804) Tissue Pathology biopsy report
158
1185
1.56
4.31
2.6
2.1
—
—
—
0
0
(3037756) Immunofixation for Serum or Plasma
19
67
2.93
4.29
1.2
1.6
—
—
—
0
0
(3015377) Calcium [Moles/volume] in Serum or Plasma
138
1007
1.57
4.23
4.3
3.3
mmol/l
2.3
2.3
0.36
124
876
(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma
50
275
1.94
4.21
2.8
2.5
ug/l
7.2
7.4
0.04
45
242
(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma
47
253
1.98
4.21
2.4
2.8
ng/l
255.1
231.1
0.15
41
222
(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay
9
13
7.06
4.18
1.2
1.2
—
—
—
0
0
(3022313) Gas panel - Capillary blood
33
158
2.19
4.01
4.0
3.6
—
—
—
0
0
(3037121) Protein [Mass/volume] in Urine
26
113
2.39
3.94
3.8
3.5
g/l
0.2
0.2
0.06
17
45
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
250
2102
1.53
3.87
7.4
3.3
u/l
75.8
51.6
2.05
235
1973
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
17
61
2.87
3.74
1.4
1.4
—
—
—
0
0
(3007847) Interleukin 2 Receptor Soluble [Units/volume] in Serum or Plasma
8
12
6.78
3.69
1.9
2.0
u/ml
1913.5
657.4
—
8
12
(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood
9
16
5.73
3.68
2.0
2.9
—
—
—
0
0
(3007164) IgA [Mass/volume] in Serum or Plasma
88
594
1.62
3.68
1.9
1.4
g/l
2.9
2.6
0.53
64
374
(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection
13
40
3.33
3.66
1.9
1.7
—
—
—
0
0
(3021960) Folate [Moles/volume] in Serum or Plasma
105
745
1.56
3.55
2.0
1.5
nmol/l
19.1
20.7
0.46
96
628
(3001964) Herpes simplex virus Ag [Presence] in Specimen
6
6
10.13
3.51
2.0
1.5
—
—
—
0
0
(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay
12
36
3.41
3.50
1.4
1.3
u/ml
4.4
1.7
—
5
10
(3019060) Gas panel - Arterial blood
41
225
1.92
3.49
11.4
6.6
—
—
—
0
0
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
16
58
2.83
3.46
1.7
1.7
—
—
—
0
0
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
81
544
1.62
3.44
4.0
2.9
mmol/l
2.4
2.4
0.06
64
475
(3004490) Bicarbonate [Moles/volume] standard in Capillary blood
28
134
2.17
3.43
4.4
4.0
mmol/l
25.4
25.1
0.28
28
127
(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex
8
14
5.81
3.35
1.3
1.1
—
—
—
0
0
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
125
939
1.49
3.20
3.4
3.2
ng/l
2518.0
1302.3
0.50
111
803
(3011397) Hemoglobin [Presence] in Urine by Test strip
95
679
1.53
3.07
4.5
3.5
—
—
—
0
0
(3011412) CD3 cells [#/volume] in Blood
10
29
3.51
3.06
1.9
2.2
e9/l
1.7
0.9
—
5
12
(21494814) CD8 cells/100 lymphocytes in Specimen
6
8
7.59
3.06
1.8
1.9
—
—
—
0
0
(3012516) Albumin [Mass/volume] in Urine
125
952
1.46
2.95
3.3
3.2
mg/l
1633.0
130.1
1.03
85
629
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
29
150
2.01
2.93
2.9
2.4
—
—
—
0
0
(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection
8
17
4.78
2.93
1.3
1.9
—
—
—
0
0
(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection
8
17
4.78
2.93
1.3
1.9
—
—
—
0
0
(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection
8
17
4.78
2.93
1.3
1.9
—
—
—
0
0
(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection
8
17
4.78
2.93
1.3
1.9
—
—
—
0
0
(3019225) pH of Specimen
47
285
1.74
2.93
6.4
4.5
—
—
—
0
0
(3023511) Choriogonadotropin [Units/volume] in Urine
10
30
3.40
2.92
1.5
1.4
—
—
—
0
0
(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay
12
41
2.99
2.88
1.4
1.2
u/ml
12.4
4.1
—
7
18
(40767503) Oxygen content in Capillary blood by calculation
15
59
2.60
2.82
3.1
2.5
%
17.5
15.6
—
8
32
(21494755) Public health laboratory ask at order entry panel
13
307
0.40
2.79
1.3
1.3
—
—
—
0
0
(3047189) Immunofixation for 24 hour Urine
7
14
5.07
2.74
1.0
2.3
—
—
—
0
0
(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection
7
14
5.07
2.74
1.3
2.1
—
—
—
0
0
(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection
7
14
5.07
2.74
1.3
2.1
—
—
—
0
0
(3011391) Calcitriol [Moles/volume] in Serum or Plasma
8
19
4.28
2.69
1.0
1.2
—
—
—
0
0
(4035726)
44
270
1.71
2.64
2.0
1.4
—
—
—
0
0
(3020891) Body temperature
24
121
2.05
2.62
8.8
4.2
—
—
—
0
0
(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection
7
15
4.73
2.61
1.3
2.0
—
—
—
0
0
(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection
11
38
2.95
2.60
1.6
1.7
—
—
—
0
0
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
18
81
2.28
2.58
1.6
1.7
—
—
—
0
0
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
18
81
2.28
2.58
1.9
1.6
—
—
—
0
0
(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma
59
394
1.59
2.56
2.5
1.9
%
1.8
1.6
0.71
53
344
(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture
6
11
5.52
2.55
1.7
1.1
—
—
—
0
0
(4015189)
6
11
5.52
2.55
1.7
2.6
—
—
—
0
0
(3035350) Ketones [Presence] in Urine by Test strip
180
1496
1.38
2.51
5.1
3.6
estimate
0.0
0.0
0.00
35
269
(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay
7
16
4.43
2.48
1.1
1.1
—
—
—
0
0
(3037522) Nuclear Ab [Titer] in Serum
58
389
1.58
2.47
1.3
1.3
titre
577.1
433.0
0.16
14
91
(3047181) Lactate [Moles/volume] in Blood
21
103
2.10
2.46
15.3
11.5
mmol/l
1.9
1.3
1.34
16
88
(3044927) Protein electrophoresis panel - Urine
10
34
2.99
2.43
1.0
1.1
—
—
—
0
0
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
15
64
2.40
2.42
1.4
1.3
—
—
—
0
0
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
335
3109
1.57
2.41
44.6
14.6
mg/l
31.5
23.6
4.79
309
2464
(3008536) Aspergillus sp Ab [Presence] in Serum
5
8
6.31
2.38
1.4
1.5
—
—
—
0
0
(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC
7
17
4.17
2.37
1.9
1.9
—
—
—
0
0
(3043409) Potassium [Moles/volume] in Arterial blood
21
105
2.06
2.35
7.5
3.4
mmol/l
3.8
4.0
0.98
21
94
(4027681)
6
13
4.67
2.28
1.2
1.2
—
—
—
0
0
(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood
9
29
3.15
2.24
3.8
2.9
—
38.2
—
0
7
(40758292) HTLV I+II Ab panel - Serum
5
9
5.61
2.22
1.2
1.6
—
—
—
0
0
(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method
10
36
2.82
2.21
1.2
1.4
—
—
—
0
0
(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
11
42
2.67
2.20
1.1
1.1
—
—
—
0
0
(3009214) Lutropin [Units/volume] in Serum or Plasma
17
81
2.15
2.16
1.5
1.3
u/l
6.4
8.9
0.59
12
67
(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
50
335
1.57
2.15
2.7
4.6
ug/l
5.3
39.3
0.84
43
285
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
15
68
2.25
2.14
1.1
1.1
—
—
—
0
0
(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection
9
31
2.95
2.08
2.1
1.5
—
—
—
0
0
(3019550) Sodium [Moles/volume] in Serum or Plasma
342
3216
1.54
2.01
45.0
17.0
mmol/l
139.1
139.7
4.72
337
3130
(3000570) Elastase.pancreatic [Mass/mass] in Stool
17
84
2.07
1.98
1.4
1.5
ug/g
192.2
280.9
1.22
12
50
(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection
7
21
3.37
1.97
1.1
1.3
—
—
—
0
0
(3017704) Immunofixation for Urine
7
21
3.37
1.97
1.1
1.4
—
—
—
0
0
(3011648) Oxygen content in Venous blood
7
21
3.37
1.97
1.9
1.8
%
11.6
11.8
—
7
21
(3028679) Herpes simplex virus Ab [Presence] in Serum
5
11
4.59
1.94
1.2
1.1
—
—
—
0
0
(3021601) Nitrite [Presence] in Urine by Test strip
177
1509
1.32
1.94
7.0
4.9
estimate
0.0
0.0
0.00
35
271
(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma
6
16
3.79
1.94
4.3
2.9
—
—
—
0
0
(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing
6
16
3.79
1.94
1.0
1.0
—
—
—
0
0
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
318
2954
1.42
1.93
33.7
13.5
ml/min/173m2
81.8
80.5
0.42
284
2426
(3026493) Urate [Moles/volume] in Serum or Plasma
106
839
1.36
1.92
3.8
2.8
umol/l
349.4
7222.6
3.54
90
719
(3023103) Potassium [Moles/volume] in Serum or Plasma
342
3225
1.51
1.88
45.0
17.2
mmol/l
4.0
4.0
0.07
336
3137
(3009261) Glucose [Presence] in Urine by Test strip
178
1527
1.31
1.84
5.1
3.6
estimate
0.0
0.0
0.00
38
254
(3017446) Testosterone [Moles/volume] in Serum or Plasma
45
306
1.53
1.83
2.1
2.3
nmol/l
13.4
13.6
0.02
40
279
(40768797) Stomach Pathology biopsy report
57
408
1.47
1.82
1.3
1.2
—
—
—
0
0
(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection
9
35
2.61
1.81
1.3
1.8
—
—
—
0
0
(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection
9
35
2.61
1.81
1.3
1.8
—
—
—
0
0
(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection
9
35
2.61
1.81
1.3
1.8
—
—
—
0
0
(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells
6
18
3.37
1.75
1.5
1.7
—
—
—
0
0
(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells
6
18
3.37
1.75
1.5
1.7
—
—
—
0
0
(3035637) Corticotropin [Mass/volume] in Plasma
8
30
2.70
1.73
1.8
1.3
—
—
—
0
0
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
150
1266
1.30
1.73
5.0
3.7
ng/l
37.3
68.3
0.56
116
901
(21491868) Cryoglobulin [Mass/volume] in Serum
5
13
3.88
1.72
1.2
1.1
—
—
—
0
0
(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma
12
55
2.22
1.69
1.5
1.4
—
99.8
—
0
12
(3020682) Albumin/Creatinine [Ratio] in Urine
123
1018
1.30
1.62
4.3
3.9
mg/mmol
27.2
9.4
0.88
87
664
(3005757) Coagulation factor V activity actual/normal in Platelet poor plasma by Coagulation assay
5
14
3.60
1.62
1.8
3.5
%
94.6
97.1
—
5
14
(3002222) Hepatitis E virus IgM Ab [Presence] in Serum
5
14
3.60
1.62
1.0
1.1
—
—
—
0
0
(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay
5
14
3.60
1.62
1.0
1.1
—
—
—
0
0
(3002385) Erythrocyte distribution width [Ratio]
281
2586
1.31
1.61
44.9
18.0
%
14.4
13.7
8.98
271
2533
(3021901) Oxygen saturation in Capillary blood
13
64
2.07
1.56
3.8
2.2
—
—
—
0
0
(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection
8
33
2.45
1.54
1.4
1.4
—
—
—
0
0
(3019832) Treponema pallidum Ab [Presence] in Serum
30
194
1.59
1.54
1.4
1.6
—
—
—
0
0
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
209
1862
1.27
1.51
3.2
2.8
—
—
—
0
0
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
10
45
2.25
1.47
1.4
1.3
—
—
—
0
0
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
15
80
1.91
1.46
1.3
1.4
—
—
—
0
0
(3006922) Hepatitis E virus Ab [Presence] in Serum
5
16
3.15
1.44
1.0
1.1
—
—
—
0
0
(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay
6
22
2.75
1.44
1.5
1.2
—
—
—
0
0
(4306422)
9
40
2.28
1.41
1.1
1.3
—
—
—
0
0
(3047007) Chlamydophila sp Ab [Presence] in Serum
9
40
2.28
1.41
1.1
1.2
—
—
—
0
0
(3037692) Legionella sp identified in Specimen by Organism specific culture
5
17
2.97
1.36
2.2
1.2
—
—
—
0
0
(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay
9
43
2.12
1.31
1.1
1.1
—
—
—
0
0
(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
8
34
2.38
1.30
1.9
1.6
—
—
—
0
0
(44816844) Macroprolactin [Units/volume] in Serum or Plasma
5
18
2.80
1.29
1.0
1.4
—
—
—
0
0
(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection
10
48
2.11
1.28
1.5
1.4
—
—
—
0
0
(3025468) Yersinia sp identified in Specimen by Organism specific culture
10
48
2.11
1.28
1.5
1.4
—
—
—
0
0
(3022806) Fractional oxyhemoglobin in Capillary blood
8
35
2.31
1.27
2.1
1.7
%
79.9
90.6
—
8
35
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
16
92
1.77
1.27
1.4
2.3
—
—
—
0
0
(3003327) Ova and parasites identified in Stool by Light microscopy
16
92
1.77
1.27
1.6
1.5
—
—
—
0
0
(3016921) Smith extractable nuclear Ab [Units/volume] in Serum
13
70
1.89
1.25
1.4
1.3
u/ml
2.9
3.3
—
5
11
(3011363) Streptococcus pneumoniae Ag [Presence] in Urine
6
25
2.42
1.25
1.0
1.2
—
—
—
0
0
(3024891) Influenza virus A+B Ag [Presence] in Specimen
15
85
1.80
1.24
1.3
1.2
—
—
—
0
0
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
11
56
1.99
1.23
1.3
1.0
—
—
—
0
0
(3005988) Vibrio sp identified in Specimen by Organism specific culture
10
49
2.07
1.23
1.5
1.4
—
—
—
0
0
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
21
319
0.64
1.19
1.2
1.6
—
—
—
0
0
(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma
8
38
2.13
1.19
1.8
1.5
—
—
—
0
0
(3003694) ABO and Rh group [Type] in Blood
99
829
1.26
1.17
1.4
1.3
—
—
—
0
0
(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection
5
20
2.52
1.15
1.8
1.4
—
—
—
0
0
(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection
5
20
2.52
1.15
1.8
1.4
—
—
—
0
0
(40768806) Pleura Pathology biopsy report
7
30
2.36
1.13
1.3
1.7
—
—
—
0
0
(40760892) CBC W Ordered Manual Differential panel - Blood
85
702
1.27
1.12
7.6
5.3
—
—
—
0
0
(40766048) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum by Immunoassay
5
21
2.40
1.09
1.2
1.2
—
—
—
0
0
(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence
7
33
2.14
1.06
1.4
1.2
—
—
—
0
0
(3012447) Hantavirus puumala IgG Ab [Titer] in Serum
7
34
2.08
1.03
1.1
1.1
—
—
—
0
0
(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection
9
47
1.94
1.03
1.4
1.4
—
—
—
0
0
(3048689) Calprotectin [Mass/mass] in Stool
46
354
1.34
1.02
3.4
2.4
ug/g
311.1
129.9
0.60
39
284
(3024522) Salmonella sp identified in Specimen by Organism specific culture
9
48
1.90
1.01
1.6
1.4
—
—
—
0
0
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
9
48
1.90
1.01
1.9
1.5
—
—
—
0
0
(3012568) Campylobacter sp identified in Specimen by Organism specific culture
9
48
1.90
1.01
1.6
1.4
—
—
—
0
0
(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay
7
35
2.02
1.00
1.3
1.0
—
—
—
0
0
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
11
187
0.58
1.00
1.1
1.5
—
—
—
0
0
(3041067) Sjogrens syndrome-A extractable nuclear 52kD Ab [Units/volume] in Serum
5
23
2.19
0.98
1.2
1.2
—
72.2
—
0
5
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
293
2774
1.23
0.98
4.7
4.4
mu/l
1.8
1.9
1.25
261
2518
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
9
50
1.82
0.97
1.7
1.5
—
—
—
0
0
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
8
145
0.54
0.95
1.1
1.0
—
—
—
0
0
(4024509)
6
27
2.24
0.94
1.5
1.3
—
—
—
0
0
(3019150) Specific gravity of Urine by Refractometry
79
662
1.24
0.93
5.3
3.9
kg/l
1.0
1.0
—
10
93
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
9
52
1.75
0.93
3.2
2.6
—
—
—
0
0
(3016650) Hepatitis A virus Ab [Presence] in Serum
11
63
1.77
0.91
1.4
1.0
—
—
—
0
0
(3030981) Hyaline casts [#/volume] in Urine by Automated count
25
177
1.44
0.91
2.2
2.6
e6/l
0.4
0.1
1.38
25
170
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
19
276
0.67
0.90
1.5
1.8
—
—
—
0
0
(3028531) Enolase.neuron specific [Mass/volume] in Serum or Plasma
8
42
1.92
0.89
1.4
2.0
ug/l
15.8
16.4
—
8
42
(3005322) IgE [Units/volume] in Serum or Plasma
23
161
1.46
0.89
1.3
1.3
u/ml
1256.7
341.4
0.89
23
146
(40761511) CBC panel - Blood by Automated count
339
3272
1.29
0.88
30.1
13.6
—
—
—
0
0
(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay
6
30
2.02
0.87
1.0
1.1
u/ml
—
—
—
0
0
(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay
6
30
2.02
0.87
1.3
1.2
—
—
—
0
0
(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma
8
45
1.79
0.84
1.4
1.1
g/l
1.4
1.5
—
8
40
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
17
248
0.67
0.84
1.1
1.4
—
—
—
0
0
(36660697) Celiac disease serology panel - Serum
29
215
1.38
0.83
1.2
1.2
—
—
—
0
0
(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma
6
32
1.89
0.82
1.5
1.2
u/l
57.5
49.8
—
6
20
(3000093) Morphology [Interpretation] in Blood Narrative
6
32
1.89
0.82
1.0
1.2
—
—
—
0
0
(40761536) Microorganisms panel - Urine sediment
32
242
1.35
0.82
7.0
3.8
—
—
—
0
0
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
299
3113
0.83
0.81
4.4
4.6
mmol/l
4.4
4.6
3.74
275
2886
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
297
3094
0.83
0.81
4.3
4.5
mmol/l
1.4
1.4
1.78
266
2851
(40766800) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ T-cells [Units/volume] corrected for background in Blood
6
33
1.83
0.79
1.0
1.2
—
—
—
0
0
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
8
48
1.68
0.79
1.1
1.6
—
—
—
0
0
(3013139) Helicobacter pylori Ag [Presence] in Stool
24
174
1.40
0.79
1.3
1.2
—
—
—
0
0
(40759836) Histone Ab [Presence] in Serum by Immunoblot
5
24
2.10
0.75
1.0
1.2
—
—
—
0
0
(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection
5
24
2.10
0.75
1.4
1.6
—
—
—
0
0
(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot
5
24
2.10
0.75
1.0
1.2
—
—
—
0
0
(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot
5
24
2.10
0.75
1.0
1.2
—
—
—
0
0
(3022145) Colonoscopy Study observation
44
354
1.27
0.74
1.5
1.3
—
—
—
0
0
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
15
100
1.52
0.74
1.7
1.6
—
—
—
0
0
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
303
2906
1.19
0.73
6.5
6.0
mmol/mol
40.3
40.3
0.01
278
2703
(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot
5
25
2.01
0.73
1.0
1.2
—
—
—
0
0
(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal
5
25
2.01
0.73
5.0
1.1
—
—
—
0
0
(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot
5
25
2.01
0.73
1.0
1.2
—
—
—
0
0
(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot
5
25
2.01
0.73
1.0
1.2
—
—
—
0
0
(3045414) Leukocytes [Presence] in Urine
18
126
1.45
0.71
2.6
1.8
—
—
—
0
0
(3030905) Polymorphonuclear cells [#/volume] in Blood
9
57
1.59
0.71
5.7
3.1
e9/l
5.7
4.5
—
9
57
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
57
476
1.23
0.71
1.2
1.4
—
—
—
0
0
(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain
7
41
1.72
0.70
1.0
1.1
—
—
—
0
0
(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
10
61
1.66
0.69
1.3
1.2
—
—
—
0
0
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
9
59
1.54
0.69
6.7
3.5
%
67.2
58.4
—
9
59
(3042111) Morphology [Interpretation] in Bone marrow Narrative
9
59
1.54
0.69
1.1
1.7
—
—
—
0
0
(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method
7
42
1.68
0.68
1.3
1.0
—
—
—
0
0
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
149
1361
1.15
0.68
4.7
4.8
ug/l
1.7
2.4
1.71
127
1226
(3039443) Prostate specific Ag panel - Serum or Plasma
5
95
0.52
0.67
1.0
1.6
—
—
—
0
0
(40768441) Liver Pathology biopsy report
5
28
1.80
0.66
1.0
1.3
—
—
—
0
0
(44816559) Phosphatidylethanol [Mass/volume] in Blood
12
78
1.56
0.66
1.2
1.3
—
—
—
0
0
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
26
333
0.77
0.62
1.2
1.5
—
—
—
0
0
(3045424) Erythrocytes [Presence] in Urine
8
52
1.55
0.60
2.0
1.4
—
—
—
0
0
(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
8
52
1.55
0.60
1.1
1.1
—
—
—
0
0
(3008364) Apolipoprotein A-I [Mass/volume] in Serum or Plasma
0
22
0.00
0.59
0.0
1.3
—
—
—
0
0
(3014051) Protein [Presence] in Urine by Test strip
10
64
1.58
0.59
3.0
2.0
—
—
—
0
0
(3004616) Nuclear Ab [Presence] in Serum
6
35
1.73
0.58
1.3
1.3
—
—
—
0
0
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
10
65
1.55
0.56
1.7
1.6
—
—
—
0
0
(3009340) Metanephrine [Moles/volume] in Serum or Plasma
6
38
1.59
0.54
1.5
1.3
nmol/l
—
—
—
0
0
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
89
796
1.15
0.54
2.9
2.9
ug/l
0.6
0.7
1.98
56
512
(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma
6
39
1.55
0.53
1.3
1.3
—
—
—
0
0
(3038177) Helicobacter pylori Ab [Presence] in Serum
6
39
1.55
0.53
1.7
1.2
—
—
—
0
0
(3023419) Bacteria identified in Sputum by Culture
6
39
1.55
0.53
2.3
3.0
—
—
—
0
0
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
55
474
1.19
0.52
1.4
1.3
iu/ml
20.2
37.1
1.15
15
161
(1761482) Bacteria [#/volume] in Urine by Culture
6
100
0.59
0.52
11.0
4.9
—
—
—
0
0
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
236
2251
1.12
0.51
4.0
3.6
pmol/l
15.0
14.8
0.76
214
2025
(42529406) Shigella sp [Presence] in Stool by Culture
14
101
1.40
0.50
1.5
1.2
—
—
—
0
0
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
308
3166
0.87
0.50
4.9
5.0
mmol/l
2.5
2.7
5.10
280
2915
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
75
669
1.15
0.47
1.8
1.8
pmol/l
535.5
433.2
0.85
67
559
(3044889) 12 lead EKG panel
232
2219
1.11
0.46
4.7
3.9
—
—
—
0
0
(4268621)
5
31
1.62
0.43
2.6
2.3
—
—
—
0
0
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
118
1092
1.12
0.43
3.7
4.2
%
19.6
20.9
0.29
48
496
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
8
57
1.41
0.42
1.1
1.6
—
—
—
0
0
(3025941) Bacteria identified in Stool by Culture
21
168
1.26
0.41
1.3
1.3
—
—
—
0
0
(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood
0
17
0.00
0.40
0.0
3.4
—
—
—
0
0
(3035062) Alkaline phosphatase.liver 1 [Enzymatic activity/volume] in Serum or Plasma
0
17
0.00
0.40
0.0
1.1
—
78.4
—
0
12
(3053028) Streptococcus sp identified in Specimen by Organism specific culture
0
17
0.00
0.40
0.0
1.1
—
—
—
0
0
(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood
0
17
0.00
0.40
0.0
3.4
—
—
—
0
0
(3036185) Alkaline phosphatase.liver 2 [Enzymatic activity/volume] in Serum or Plasma
0
17
0.00
0.40
0.0
1.1
—
26.8
—
0
12
(3015024) Glucose [Moles/volume] in Serum or Plasma --1 hour post dose glucose
0
18
0.00
0.40
0.0
1.7
—
7.5
—
0
11
(21494434) Karyotype in Bone marrow
5
35
1.43
0.39
1.2
1.1
—
—
—
0
0
(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]
0
19
0.00
0.39
0.0
1.4
—
—
—
0
0
(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay
0
19
0.00
0.39
0.0
1.0
—
39.6
—
0
10
(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid
0
19
0.00
0.39
0.0
1.0
—
580.6
—
0
11
(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid
0
19
0.00
0.39
0.0
1.0
—
260.4
—
0
11
(3002256) Pathology report gross observation
41
356
1.17
0.38
1.4
1.3
—
—
—
0
0
(3009542) Hematocrit [Volume Fraction] of Blood
292
2842
1.11
0.37
42.6
15.7
%
38.1
40.4
4.30
204
2051
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
13
99
1.32
0.36
1.5
1.2
—
—
—
0
0
(1002224) Polysomnography panel
10
134
0.74
0.35
1.1
1.1
—
—
—
0
0
(3045142) Bone marrow Pathology biopsy report
6
43
1.40
0.35
1.8
1.2
—
—
—
0
0
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
58
643
0.88
0.34
1.4
1.2
u/ml
0.7
1.4
—
7
190
(40761535) Cells panel - Urine sediment
30
256
1.19
0.34
4.9
3.3
—
—
—
0
0
(3014765) Yersinia sp identified in Stool by Organism specific culture
13
100
1.31
0.34
1.5
1.2
—
—
—
0
0
(40768800) Prostate Pathology biopsy report
12
92
1.31
0.32
1.3
1.2
—
—
—
0
0
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
294
3005
0.91
0.31
4.0
4.1
mmol/l
1.4
1.3
0.99
269
2766
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
338
3328
1.12
0.29
25.3
10.8
u/l
30.3
27.4
1.22
331
3219
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
28
244
1.16
0.26
2.0
2.7
ml/min/173m2
59.4
63.3
0.20
16
106
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
12
95
1.27
0.26
1.8
1.7
—
—
—
0
0
(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay
6
85
0.70
0.24
1.3
1.1
—
11.1
—
0
9
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
29
256
1.14
0.24
2.0
2.0
—
—
—
0
0
(44790047)
5
40
1.25
0.22
2.2
1.6
—
—
—
0
0
(44806118)
5
40
1.25
0.22
2.2
1.6
—
—
—
0
0
(44790049)
5
40
1.25
0.22
2.2
1.6
—
—
—
0
0
(44790048)
5
40
1.25
0.22
2.2
1.6
—
—
—
0
0
(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum
0
10
0.00
0.21
0.0
1.1
—
—
—
0
0
(3009804) Carcinoembryonic Ag [Mass/volume] in Pleural fluid
0
12
0.00
0.21
0.0
1.2
—
1.3
—
0
5
(44813793)
0
12
0.00
0.21
0.0
1.0
—
—
—
0
0
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
114
1193
0.94
0.21
6.1
3.7
—
—
—
0
0
(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid
0
14
0.00
0.20
0.0
1.1
—
—
—
0
0
(4010399)
26
231
1.13
0.20
1.7
1.4
—
—
—
0
0
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
48
448
1.08
0.16
1.3
1.3
u/ml
5.1
11.6
0.73
16
174
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
8
70
1.15
0.16
1.6
1.3
—
—
—
0
0
(3000492) Spirometry study
34
312
1.10
0.16
1.6
1.4
—
—
—
0
0
(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma
15
172
0.87
0.16
1.0
1.2
iu/ml
63.8
152.4
—
5
64
(3049717) Cytology report of Urine Cyto stain
16
140
1.15
0.15
2.2
2.7
—
—
—
0
0
(4094501)
7
86
0.81
0.14
1.1
1.1
—
—
—
0
0
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
7
89
0.78
0.14
1.3
2.2
—
—
—
0
0
(3029937) Albumin [Presence] in Urine by Test strip
85
815
1.05
0.14
6.4
3.8
estimate
0.0
0.0
0.50
35
256
(3013512) EKG study
97
936
1.05
0.13
4.9
4.0
—
—
—
0
0
(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay
5
46
1.09
0.09
1.4
1.6
—
—
—
0
0
(3000330) Specific gravity of Urine by Test strip
18
165
1.10
0.09
6.4
4.0
—
—
—
0
0
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
6
57
1.05
0.08
1.3
1.8
—
—
—
0
0
(3017732) Neutrophils [#/volume] in Blood
23
215
1.07
0.08
6.8
2.9
e9/l
4.0
4.0
0.03
15
166
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
83
852
0.97
0.07
1.8
1.7
mmol/l
1.3
1.4
0.77
69
708
(3007461) Platelets [#/volume] in Blood
348
3464
1.04
0.06
54.3
21.5
e9/l
261.6
244.1
4.20
341
3378
(3024731) MCV [Entitic volume]
348
3465
1.04
0.05
53.9
21.4
fl
91.0
91.2
0.18
343
3415
(3022621) pH of Urine by Test strip
22
208
1.06
0.05
3.5
2.4
—
—
—
0
0
(3035941) MCH [Entitic mass]
348
3466
1.04
0.05
53.8
21.4
pg
30.0
30.4
3.34
343
3416
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
10
110
0.91
0.05
1.4
2.2
—
—
—
0
0
(3026361) Erythrocytes [#/volume] in Blood
348
3467
1.04
0.04
54.1
21.5
e12/l
4.3
4.5
10.51
338
3370
(40768443) Skin Pathology biopsy report
15
140
1.07
0.04
1.3
1.2
—
—
—
0
0
(3010813) Leukocytes [#/volume] in Blood
348
3468
1.03
0.04
54.1
21.5
e9/l
7.3
6.7
4.68
339
3367
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
39
401
0.97
0.03
4.6
4.5
%
30.7
31.2
0.11
30
267
(3000963) Hemoglobin [Mass/volume] in Blood
348
3469
1.03
0.03
54.5
21.6
g/l
127.3
137.2
19.02
342
3414
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
38
371
1.03
0.02
10.9
8.3
—
—
—
0
0
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
24
232
1.04
0.02
2.0
1.8
—
—
—
0
0
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
305
3043
1.01
0.01
4.8
4.6
mmol/l
6.1
6.0
0.30
275
2778
(3004716) Salmonella sp identified in Stool by Organism specific culture
15
156
0.96
0.00
1.4
1.3
—
—
—
0
0
(3008898) HLA-B27 [Presence]
10
98
1.02
0.00
1.0
1.1
—
—
—
0
0
(3041096) Erythrocytes [Presence] in Urine by Automated
85
848
1.00
0.00
5.2
3.3
—
—
—
0
0
(3018851) Theophylline [Moles/volume] in Serum or Plasma
0
7
0.00
0.00
0.0
1.4
—
39.1
—
0
7
(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(36304052) Adalimumab Ab [Units/volume] in Serum or Plasma
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3033705) Calcium.ionized [Moles/volume] in Venous blood
5
50
1.00
0.00
7.8
3.0
—
—
—
0
0
(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain
6
62
0.97
0.00
2.0
1.4
—
—
—
0
0
(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum
0
9
0.00
0.00
0.0
1.0
—
9.5
—
0
9
(40770918) von Willebrand factor (vWf).activity actual/normal in Platelet poor plasma by Immunoassay
0
9
0.00
0.00
0.0
1.0
—
133.6
—
0
9
(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(40758355) Pancreatic polypeptide [Moles/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
3.0
—
59.4
—
0
6
(40763634) TCRG gene rearrangements [Presence] in Bone marrow by Molecular genetics method
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(3036035) von Willebrand factor (vWf) Ag actual/normal in Platelet poor plasma by Immunoassay
0
5
0.00
0.00
0.0
1.0
—
194.0
—
0
5
(3000285) Sodium [Moles/volume] in Blood
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3000213) Normetanephrine [Moles/time] in 24 hour Urine
0
6
0.00
0.00
0.0
1.2
—
1.8
—
0
6
(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection
0
9
0.00
0.00
0.0
1.7
—
—
—
0
0
(3006462) Nitrate [Presence] in Urine
0
9
0.00
0.00
0.0
1.8
—
—
—
0
0
(40761995) Spermatozoa Progressive [#/volume] in Semen
0
9
0.00
0.00
0.0
2.9
—
—
—
0
0
(40765089) Chromosome analysis panel - Blood by G-banded
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(4133840)
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(3014043) Spermatozoa Nonprogressive/100 spermatozoa in Semen
0
9
0.00
0.00
0.0
5.8
—
—
—
0
0
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
6
65
0.92
0.00
1.2
1.5
—
—
—
0
0
(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal
0
6
0.00
0.00
0.0
1.5
—
—
—
0
0
(3028009) Chlamydia trachomatis IgG Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum
0
8
0.00
0.00
0.0
1.3
—
—
—
0
0
(3034426) Prothrombin time (PT)
0
9
0.00
0.00
0.0
1.3
—
—
—
0
0
(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3021162) Amylase [Enzymatic activity/volume] in Specimen
0
8
0.00
0.00
0.0
1.9
—
9111.9
—
0
8
(3009876) Amylase isoenzyme 3 panel - Serum or Plasma
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3013803) Aspergillus fumigatus IgG Ab [Mass/volume] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3051101) Glucose [Moles/volume] in Cord blood
0
5
0.00
0.00
0.0
6.0
—
—
—
0
0
(3026051) Polymorphonuclear cells/100 leukocytes in Pleural fluid
0
5
0.00
0.00
0.0
1.6
—
24.4
—
0
5
(44806071)
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3028371) Actinomyces sp identified in Specimen by Organism specific culture
0
5
0.00
0.00
0.0
1.8
—
—
—
0
0
Mortality – FinRegistry
↥Association
Association between endpoint G6_CNSABSC and mortality.
Females
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| G6_CNSABSC | 2.858 [2.2, 3.71] | < 0.001 |
| Birth year | 0.996 [0.99, 1.0] | 0.345 |
During the follow-up period (1.1.1998 — 31.12.2019), 249 out of 827 females with G6_CNSABSC died.
Males
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| G6_CNSABSC | 3.057 [2.48, 3.77] | < 0.001 |
| Birth year | 0.984 [0.97, 0.99] | 0.002 |
During the follow-up period (1.1.1998 — 31.12.2019), 456 out of 1360 males with G6_CNSABSC died.
Mortality risk
Mortality risk for people of age
years, who have G6_CNSABSC.| N-year risk | Females | Males |
|---|---|---|
| 1 | 0.342% | 0.607% |
| 5 | 2.032% | 3.043% |
| 10 | 4.479% | 7.957% |
| 15 | 7.857% | 15.197% |
| 20 | 13.336% | 24.356% |
Relationships between endpoints
↥Index endpoint: G6_CNSABSC – Intracranial and intraspinal abscess and granuloma
GWS hits: -
Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
rg [CI]
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
Loading data